| Sunitinib rechallenge in metastatic renal cell carcinoma patients - Abstract - UroToday |
|
|
UroToday Sunitinib was a standard initial therapy in metastatic renal cell carcinoma (mRCC). Given the fact that many patients progressed through many available |